[Antihypertensive effect and adverse effects of treatment with beta-blocking agents]. 1975

O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010096 Oxprenolol A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Coretal,Koretal,Oxprenolol Hydrochloride,Slow Trasicor,Tevacor,Trasicor,Hydrochloride, Oxprenolol,Trasicor, Slow
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D004417 Dyspnea Difficult or labored breathing. Orthopnea,Platypnea,Recumbent Dyspnea,Rest Dyspnea,Trepopnea,Breathlessness,Shortness of Breath,Breath Shortness,Dyspnea, Recumbent,Dyspnea, Rest,Dyspneas, Rest
D005260 Female Females

Related Publications

O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
June 1979, Journal of medicinal chemistry,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
January 1968, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
January 1988, Drugs,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
January 1980, Archives internationales de pharmacodynamie et de therapie,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
February 1979, Archives internationales de pharmacodynamie et de therapie,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
January 1985, Journal of cardiovascular pharmacology,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
May 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
March 1975, Lakartidningen,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
December 1977, La Nouvelle presse medicale,
O Andersson, and G Berglund, and H Bergman, and K Cramér, and S E Fagerberg, and S A Forsberg, and V Johnsen, and L Lundkvist, and O Rutle, and R Sjolyst
December 1975, La Nouvelle presse medicale,
Copied contents to your clipboard!